{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:04:04Z","timestamp":1781103844953,"version":"3.54.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-breast-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.clbc.2024.03.007","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T08:08:17Z","timestamp":1710403697000},"page":"399-410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hypofractionation for Regional Nodal Irradiation in Breast Cancer: Best of Both the Worlds"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6185-4139","authenticated-orcid":false,"given":"Budhi Singh","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Treshita","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9804","key":"10.1016\/j.clbc.2024.03.007_bib0001","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials, early breast cancer trialists","volume":"378","author":"Darby","year":"2011","journal-title":"Lancet"},{"issue":"9935","key":"10.1016\/j.clbc.2024.03.007_bib0002","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","article-title":"Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials","volume":"383","author":"McGale","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2024.03.007_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103090","article-title":"The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: a critical review","volume":"156","author":"Marta","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"issue":"15","key":"10.1016\/j.clbc.2024.03.007_bib0004","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/jnci\/94.15.1143","article-title":"Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer","volume":"94","author":"Whelan","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.clbc.2024.03.007_bib0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2005.01.005","article-title":"Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial","volume":"75","author":"Yarnold","year":"2005","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.clbc.2024.03.007_bib0006","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clon.2020.12.008","article-title":"The financial impact on reimbursement of moderately hypofractionated postoperative radiation therapy for breast cancer: an international consortium report","volume":"33","author":"Marta","year":"2021","journal-title":"Clin Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2024.03.007_bib0007","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0360-3016(03)00579-0","article-title":"Activity-based costing: a practical model for cost calculation in radiotherapy","volume":"57","author":"Lievens","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.clbc.2024.03.007_bib0008","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2024.03.007_bib0010","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1470-2045(18)30813-1","article-title":"Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial","volume":"20","author":"Wang","year":"2019","journal-title":"Lancet Oncol"},{"issue":"31","key":"10.1016\/j.clbc.2024.03.007_bib0011","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1200\/JCO.20.01024","article-title":"Hypofractionated versus conventional fractionated radiotherapy after breast-conserving surgery in the modern treatment era: a multicenter, randomized controlled trial from China","volume":"38","author":"Wang","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2024.03.007_bib0012","doi-asserted-by":"crossref","first-page":"100392","DOI":"10.1016\/j.lansea.2024.100392","article-title":"Preliminary results of hypofractionated radiotherapy in breast cancer in Chandigarh, India: single-centre, non-inferiority, open-label, randomised, phase 3 trial","volume":"24","author":"Yadav","year":"2024","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"10.1016\/j.clbc.2024.03.007_bib0013","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1748-717X-7-80","article-title":"Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial","volume":"7","author":"Van Parijs","year":"2012","journal-title":"Radiat Oncol"},{"issue":"18","key":"10.1016\/j.clbc.2024.03.007_bib0015","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1200\/JCO.2016.70.7158","article-title":"Hypofractionated postmastectomy radiation therapy is safe and effective: first results from a prospective phase ii trial","volume":"35","author":"Khan","year":"2017","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2024.03.007_bib0016","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/apjon.apjon_46_17","article-title":"A comparative study of hypofractionated and conventional radiotherapy in postmastectomy breast cancer patients","volume":"5","author":"Rastogi","year":"2018","journal-title":"Asia-Pacific J Oncol Nurs"},{"issue":"2","key":"10.1016\/j.clbc.2024.03.007_bib0017","first-page":"121","article-title":"Normal tissue complications following hypofractionated chest wall radiotherapy in breast cancer patients and their correlation with patient, tumor, and treatment characteristics","volume":"38","author":"Khan","year":"2017","journal-title":"Indian J Med Paediatr Oncol"},{"key":"10.1016\/j.clbc.2024.03.007_bib0019","first-page":"503","article-title":"Breast cancer hypofractionated radiotherapy in 2-weeks with 2D technique: 5-year clinical outcomes of a phase 2 trial","volume":"26","author":"Yadav","year":"2021","journal-title":"Rep Pract Oncol Radiother"},{"issue":"4","key":"10.1016\/j.clbc.2024.03.007_bib0020","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4103\/ijc.IJC_670_18","article-title":"Assessment of toxicities and outcomes in patients with breast cancer treated with hypofractionated radiotherapy","volume":"57","author":"Sindhu","year":"2020","journal-title":"Indian J Cancer"},{"issue":"3","key":"10.1016\/j.clbc.2024.03.007_bib0021","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/j.ijrobp.2020.07.1051","article-title":"Clinical outcomes, cosmesis and quality of life in hypofractionation versus conventional fractionation radiotherapy to whole breast and regional nodes: a phase ii randomized study","volume":"108","author":"Kumar","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.clbc.2024.03.007_bib0022","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3857\/roj.2020.00129","article-title":"Late-term effects of hypofractionated chest wall and regional nodal radiotherapy with two-dimensional technique in patients with breast cancer","volume":"38","author":"Yadav","year":"2020","journal-title":"Radiat Oncol J"},{"issue":"3","key":"10.1016\/j.clbc.2024.03.007_bib0023","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ijrobp.2016.11.010","article-title":"Hypofractionated regional nodal irradiation for women with node-positive breast cancer","volume":"97","author":"Bellefqih","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.clbc.2024.03.007_bib0024","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1016\/j.clbc.2021.09.008","article-title":"Hypofractionated radiation therapy (HFRT) of breast\/chest wall and regional nodes in locally advanced breast cancer: toxicity profile and survival outcomes in retrospective monoistitutional study","volume":"22","author":"De Matteis","year":"2022","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"10.1016\/j.clbc.2024.03.007_bib0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.31557\/APJCP.2020.21.1.119","article-title":"Comparison of treatment outcome between hypofractionated radiotherapy and conventional radiotherapy in postmastectomy breast cancer","volume":"21","author":"Tovanabutra","year":"2020","journal-title":"Asian Pacific J Cancer Prev"},{"issue":"suppl 2","key":"10.1016\/j.clbc.2024.03.007_bib0026","first-page":"S94","article-title":"A retrospective study comparing hypofractionated radiotherapy and conventional radiotherapy in postmastectomy breast cancer","volume":"94","author":"Pinitpatcharalert","year":"2011","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.clbc.2024.03.007_bib0027","first-page":"1","article-title":"Moderately hypofractionated radiation therapy for breast cancer: a Brazilian cohort study","volume":"14","author":"de Siqueira","year":"2022","journal-title":"Lancet Reg Heal Am"},{"issue":"1135","key":"10.1016\/j.clbc.2024.03.007_bib0029","doi-asserted-by":"crossref","first-page":"20211299","DOI":"10.1259\/bjr.20211299","article-title":"Outcomes and toxicity following post-operative hypofractionated radiotherapy to the regional nodes and the breast or the chest wall in locally advanced breast cancer","volume":"95","author":"Tramacere","year":"2022","journal-title":"Br J Radiol"},{"issue":"1","key":"10.1016\/j.clbc.2024.03.007_bib0031","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.ijrobp.2012.08.017","article-title":"Postmastectomy hypofractionated and accelerated radiation therapy with (and without) subcutaneous amifostine cytoprotection","volume":"85","author":"Koukourakis","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.clbc.2024.03.007_bib0032","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.3390\/curroncol28050300","article-title":"Long-term results of postoperative hypofractionated accelerated breast and lymph node radiotherapy (HypoAR) with hypofractionated boost","volume":"28","author":"Koukourakis","year":"2021","journal-title":"Curr Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2024.03.007_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-021-09032-8","article-title":"Hypofractionated radiotherapy in ten fractions for postmastectomy patients: a phase II study compared with another hypofractionation schedule with sixteen fractions","volume":"21","author":"Jiang","year":"2021","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.clbc.2024.03.007_bib0034","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3857\/roj.2021.01053","article-title":"Accelerated hypofractionated breast radiotherapy with simultaneous integrated boost: a feasibility study","volume":"40","author":"Yadav","year":"2022","journal-title":"Radiat Oncol J"},{"issue":"25","key":"10.1016\/j.clbc.2024.03.007_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/WWBF1044","article-title":"One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT","volume":"27","author":"Brunt","year":"2023","journal-title":"Health Technol Assess"},{"issue":"1","key":"10.1016\/j.clbc.2024.03.007_bib0009","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.radonc.2017.10.033","article-title":"Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: results from the UK START (Standardisation of Breast Radiotherapy) trials","volume":"126","author":"Haviland","year":"2018","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2024.03.007_bib0014","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.4103\/jcrt.JCRT_549_19","article-title":"Comparison of two radiation boost schedules in postlumpectomy patients with breast cancer","volume":"16","author":"Yadav","year":"2020","journal-title":"J Cancer Res Therapeut"},{"issue":"4","key":"10.1016\/j.clbc.2024.03.007_bib0018","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ijrobp.2017.12.015","article-title":"A phase 2 study of 2 Weeks of adjuvant whole breast\/chest wall and\/or regional nodal radiation therapy for patients with breast cancer","volume":"100","author":"Yadav","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.clbc.2024.03.007_bib0028","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4103\/0973-1482.136560","article-title":"Post-mastectomy radiation beyond chest wall in patients with N1 breast cancer: Is there a benefit?","volume":"10","author":"Yadav","year":"2014","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.clbc.2024.03.007_bib0030","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1017\/S1460396915000278","article-title":"Postmastectomy internal mammary node radiation in women with breast cancer: a long-term follow-up study","volume":"14","author":"Yadav","year":"2015","journal-title":"J Radiother Pract"},{"key":"10.1016\/j.clbc.2024.03.007_bib0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.radonc.2022.07.003","article-title":"Hyport Adjuvant Author Group HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results: interim analysis","volume":"174","author":"Chakraborty","year":"2022","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2024.03.007_bib0037","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13014-018-1040-z","article-title":"The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies","volume":"13","author":"van Leeuwen","year":"2018","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2024.03.007_bib0038","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.radonc.2011.01.010","article-title":"Is \u03b1\/\u03b2 for breast cancer really low?","volume":"100","author":"Qi","year":"2011","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2024.03.007_bib0039","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.prro.2018.01.012","article-title":"Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline","volume":"8","author":"Smith","year":"2018","journal-title":"Pract Radiat Oncol"},{"issue":"12","key":"10.1016\/j.clbc.2024.03.007_bib0040","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s11547-022-01563-9","article-title":"The Italian Association for Radiotherapy and Clinical Oncology (AIRO) position statements for postoperative breast cancer radiation therapy volume, dose, and fractionation","volume":"127","author":"Meattini","year":"2022","journal-title":"Radiol Med"},{"issue":"1","key":"10.1016\/j.clbc.2024.03.007_bib0041","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S1470-2045(21)00539-8","article-title":"European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer","volume":"23","author":"Meattini","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2024.03.007_bib0042","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.radonc.2020.10.008","article-title":"Hypofractionated radiation therapy for breast cancer: Preferences amongst radiation oncologists in Europe: results from an international survey","volume":"155","author":"Ratosa","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clbc.2024.03.007_bib0043","article-title":"Hypofractionation in breast cancer radiotherapy across World Bank Income Groups: results of an international survey","volume":"9","author":"Mushonga","year":"2023","journal-title":"JCO Glob Oncol"},{"issue":"8","key":"10.1016\/j.clbc.2024.03.007_bib0044","first-page":"1580","article-title":"Evidence-based guidelines for hypofractionated radiation in breast cancer: conclusions of the Catalan expert working group","volume":"24","author":"Eraso","year":"2022","journal-title":"Clin Transl Oncol Off Publ Fed Spanish Oncol Soc Natl Cancer Inst Mex"},{"issue":"1","key":"10.1016\/j.clbc.2024.03.007_bib0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/jamaoncol.2018.5061","article-title":"Hypofractionated nodal irradiation for breast cancer: a case for caution","volume":"5","author":"Vinh-Hung","year":"2019","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2024.03.007_bib0046","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ijrobp.2016.02.008","article-title":"Mild Lung restriction in breast cancer patients after hypofractionated and conventional radiation therapy: a 3-year follow-up","volume":"95","author":"Verbanck","year":"2016","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.clbc.2024.03.007_bib0048","doi-asserted-by":"crossref","DOI":"10.1111\/ajco.13945","article-title":"Impact of age on outcomes in young women with breast cancer","author":"Yadav","year":"2023","journal-title":"Asia Pacific J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2024.03.007_bib0049","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1017\/S1460396909990239","article-title":"Pattern of care and survival in older women with breast cancer in India","volume":"9","author":"Yadav","year":"2010","journal-title":"Journal of Radiotherapy in Practice"},{"issue":"2","key":"10.1016\/j.clbc.2024.03.007_bib0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5603\/RPOR.a2022.0028","article-title":"Hypofractionated radiotherapy in young versus older women with breast cancer: a retrospective study from India","volume":"27","author":"Yadav","year":"2022","journal-title":"Rep Pract Oncol Radiother"},{"issue":"6","key":"10.1016\/j.clbc.2024.03.007_bib0051","first-page":"1287","article-title":"Male breast cancer: outcome with adjuvant treatment","volume":"16","author":"Yadav","year":"2020","journal-title":"JCRT"},{"issue":"7","key":"10.1016\/j.clbc.2024.03.007_bib0052","first-page":"CD003860","article-title":"Fraction size in radiation therapy for breast conservation in early breast cancer","volume":"7","author":"Hickey","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"31","key":"10.1016\/j.clbc.2024.03.007_bib0047","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1200\/JCO.20.02389","article-title":"Hypofractionated whole-breast irradiation: case closed?","volume":"38","author":"Recht","year":"2020","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2024.03.007_bib0053","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijrobp.2016.10.012","article-title":"Decreased lung perfusion after breast\/chest wall irradiation: quantitative results from a prospective clinical trial","volume":"97","author":"Liss","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2024.03.007_bib0054","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/MD.0000000000033303","article-title":"Does shortening the duration of radiotherapy treatment in breast cancer increase the risk of radiation pneumonia: a retrospective study","volume":"102","author":"Tepetam","year":"2023","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.clbc.2024.03.007_bib0055","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/02841860500371907","article-title":"Radiation-induced brachial plexopathy and hypofractionated regimens in adjuvant irradiation of patients with breast cancer: a review","volume":"45","author":"Ga\u0142ecki","year":"2006","journal-title":"Acta Oncol (Madr)"},{"issue":"3","key":"10.1016\/j.clbc.2024.03.007_bib0056","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ijrobp.2013.02.018","article-title":"A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy","volume":"86","author":"Kim","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.clbc.2024.03.007_bib0057","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1245\/s10434-012-2290-x","article-title":"Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer","volume":"19","author":"Bevilacqua","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.clbc.2024.03.007_bib0058","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.ejso.2016.07.138","article-title":"Upper outer boundaries of the axillary dissection. Result of the SENTIBRAS protocol: multicentric protocol using axillary reverse mapping in breast cancer patients requiring axillary dissection","volume":"42","author":"Nos","year":"2016","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2024.03.007_bib0059","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijrobp.2018.03.046","article-title":"Radiation therapy field design and lymphedema risk after regional nodal irradiation for breast cancer","volume":"102","author":"Gross","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.clbc.2024.03.007_bib0060","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/SLA.0000000000003491","article-title":"Risk of lymphedema following contemporary treatment for breast cancer: an analysis of 7617 consecutive patients from a multidisciplinary perspective","volume":"274","author":"Byun","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2024.03.007_bib0061","unstructured":"Hypofractionated vs standard radiotherapy in breast cancer with an indication for regional lymph node irradiation about lymphedema occurrence. Available at: https:\/\/clinicaltrials.gov\/show\/NCT03127995. Accessed January 18, 2023."},{"key":"10.1016\/j.clbc.2024.03.007_bib0062","unstructured":"Hypofractionated irradiation at regional nodal area for breast cancer vs existed standard treatment (HARVEST). Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03829553. Accessed January 18, 2023."},{"issue":"9","key":"10.1016\/j.clbc.2024.03.007_bib0063","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-062034","article-title":"Hypofractionated versus conventional intensity-modulated radiation irradiation (HARVEST-adjuvant): study protocol for a randomised non-inferior multicentre phase III trial","volume":"12","author":"Xie","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.clbc.2024.03.007_bib0064","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.breast.2021.05.012","article-title":"Internal mammary node irradiation in node-positive breast cancer treated with mastectomy and taxane-based chemotherapy","volume":"59","author":"Cho","year":"2021","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.clbc.2024.03.007_bib0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13014-020-1464-0","article-title":"Optimal radiotherapy for patients with internal mammary lymph node metastasis from breast cancer","volume":"15","author":"Yang","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clbc.2024.03.007_bib0066","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.2147\/CMAR.S327666","article-title":"Radiation oncologists\u2019 approach to internal mammary lymph node radiotherapy in breast cancer: the Turkish society for radiation oncology breast cancer study group (trod 06-005 survey study)","volume":"13","author":"Eren","year":"2021","journal-title":"Cancer Manag Res"},{"issue":"12","key":"10.1016\/j.clbc.2024.03.007_bib0067","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S1470-2045(20)30472-1","article-title":"Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922\/10925): 15-year results of a randomised, phase 3 trial","volume":"21","author":"Poortmans","year":"2020","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2024.03.007_bib0068","first-page":"1122","article-title":"Dosimetric evaluation, acute toxicity and short-term efficacy of postmastectomy hypofractionated internal mammary chain irradiation with electrons","author":"Zhang","year":"2021","journal-title":"Chinese J Radiat Oncol"},{"key":"10.1016\/j.clbc.2024.03.007_bib0069","article-title":"Real-world practice of hypofractionated radiotherapy in patients with invasive breast cancer","volume":"12","author":"Chen","year":"2022","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2024.03.007_bib71","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.adro.2019.09.005","article-title":"Comparison of toxicity and cosmetic outcomes after accelerated partial breast irradiation or whole breast irradiation using 3-dimensional conformal external beam radiation therapy","volume":"5","author":"Yadav","year":"2019","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2024.03.007_bib0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13063-023-07851-7","article-title":"HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): a non-inferiority, open-label, phase III randomised trial","volume":"25","author":"Yadav","year":"2024","journal-title":"Trials"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820924000806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820924000806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T14:54:21Z","timestamp":1718895261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820924000806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1526820924000806"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2024.03.007","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypofractionation for Regional Nodal Irradiation in Breast Cancer: Best of Both the Worlds","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2024.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}